ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZugAKROSWISS AG
AKROSWISS AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Akroswiss is the development and marketing of innovative nasal treatments for central nervous system (CNS) diseases, particularly for epileptic seizures and anxiety disorders (claustrophobia) during MRI examinations. The company focuses on developing minimally invasive, intranasal drug formulations with a unique 360° function for rapid and effective administration.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

AKROSWISS AG

✓ Offered
3
Intranasal Midazolam medicinal product
Intranasal formulations with 360° functionality for the minimally invasive administration of midazolam; developed for the treatment of epileptic seizures and for conscious sedation.
Treatment of epileptic seizures
Intranasal treatment of epileptic seizures with rapid, well-tolerated and non-invasive application; described as an alternative to buccal solutions, tablets and suppositories.
Conscious sedation
Intranasal sedation for clinical situations involving anxiety or claustrophobia, particularly during MRI examinations; minimally invasive, hygienic single-use application.
Trust & reputation

ranQ Trust Score of AKROSWISS AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

AKROSWISS AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
AKROSWISS AG scores 85.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
AKROSWISS AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
AKROSWISS AG scores 0.9 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.0.94%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

AKROSWISS AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once AKROSWISS AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

AKROSWISS AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank AKROSWISS AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of AKROSWISS AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Baarerstrasse 2
6300 Zug
Opening hours
Mon
08:00 - 18:00
Tue
08:00 - 18:00
Wed
08:00 - 18:00
Thu
08:00 - 18:00
Fri
08:00 - 18:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-113.309.559
Founded
2006 · 20 years
Last commercial register change
July 24, 2025
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    RP
    Rhythm Pharmaceuticals Switzerland GmbH
    Zug
    NI
    Noveeda International GmbH
    Zug
    PP
    Primex Pharmaceuticals AG
    Zug
    PG
    Pharvaris GmbH
    Zug
    EP
    Essential Pharma Switzerland GmbH
    Zug
    MA
    Maras AG
    Cham
    CA
    Clinuvel AG
    Baar
    GA
    Gynial AG
    Rotkreuz